Using ApoE Genotyping to Promote Healthy Lifestyles in Finland – Psychological Impacts: Randomized Controlled Trial
- 5 March 2015
- journal article
- research article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 24 (6) , 908-921
Abstract
Common health recommendations often incite very little public response, as people instead require individualized information. The purpose of this study was to assess the psychological effects of personal genetic information, provided by different apoE genotypes, as a tool to promote lifestyle changes. This study was a one‐year intervention study using healthy adults, aged 20–67 years (n = 107). Their experiences of state anxiety, threat and stage of change were measured three times over a 12 months period. These psychological experiences were assessed, during the genetic information gathering, for three groups: a high‐risk group (Ɛ4+, n = 16); a low‐risk group (Ɛ4−, n = 35); and a control group (n = 56). The psychological effects of personal genetic risk information were shown to be short‐term, although the levels of state anxiety and threat experiences in the high‐risk group both remained at a slightly higher level than in the baseline. Threat experiences differed almost significantly (alpha = 0.017) between the Ɛ4+ and Ɛ4− groups (p = 0.034). Information on the apoE genotype impacted the experience of cardiovascular threat; this effect was most intense immediately after genetic feedback was received. However, fears of threat and anxiety may not be an obstacle for using gene information to motivate healthy, stable adults towards making lifestyle changes. Further studies should thus focus on how to utilize genetic screening in prevention of lifestyle‐related diseases.Keywords
This publication has 54 references indexed in Scilit:
- Stages of Change, Smoking Behaviour and Readiness to Quit in a Large Sample of Indigenous Australians Living in Eight Remote North Queensland CommunitiesInternational Journal of Environmental Research and Public Health, 2013
- Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease riskGenetics in Medicine, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskNew England Journal of Medicine, 2011
- Effects of communicating DNA-based disease risk estimates on risk-reducing behavioursCochrane Database of Systematic Reviews, 2010
- Disclosure ofAPOEGenotype for Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2009
- Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL StudyAlzheimer Disease & Associated Disorders, 2008
- Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trialBMJ, 2007
- The Hawthorne Effect: a randomised, controlled trialBMC Medical Research Methodology, 2007
- Putting the fear back into fear appeals: The extended parallel process modelCommunication Monographs, 1992